Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1990
Expression and function of gamma delta- and alpha beta-T cell receptor heterodimers on human somatic T cell hybrids
D Kozbor, M A Cassatella, S Lessin, et al.
Journal of Immunological Methods
|
July 16, 1985
Specific immunoglobulin production and enhanced tumorigenicity following ascites growth of human hybridomas
D Kozbor, W Abramow-Newerly, P Tripputi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1997
Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection
E M Hyjek, J Bartkowiak, R Drozdz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
March 23, 2005
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria
I Havlik, S Looareesuwan, S Vannaphan, et al.
The Journal of Experimental Medicine
|
May 1, 1989
Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion
D Kozbor, G Trinchieri, D S Monos, et al.
Nature
|
January 23, 1986
Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells
D Kozbor, A Giallongo, M E Sierzega, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 30, 1998
The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis
D Kmieciak, T J Wasik, H Teppler, et al.
International Immunology
|
January 14, 1999
The effect of epitope variation on the profile of cytotoxic T lymphocyte responses to the HIV envelope glycoprotein
D Kmieciak, I Bednarek, M Takiguchi, et al.
Immunology
|
July 1, 1982
Further studies of natural killer cell function in Chediak-Higashi patients
J C Roder, T Haliotis, L Laing, et al.
Cancer Immunology, Immunotherapy : CII
|
April 21, 2021
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
A J R McGray, C Eppolito, A Miliotto, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Journal of Immunology (Baltimore, Md. : 1950)
|
May 15, 1990
Expression and function of gamma delta- and alpha beta-T cell receptor heterodimers on human somatic T cell hybrids
D Kozbor, M A Cassatella, S Lessin, et al.
Journal of Immunological Methods
|
July 16, 1985
Specific immunoglobulin production and enhanced tumorigenicity following ascites growth of human hybridomas
D Kozbor, W Abramow-Newerly, P Tripputi, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1997
Evidence for B cell-mediated activation of V delta 1+ T lymphocytes during progression of HIV infection
E M Hyjek, J Bartkowiak, R Drozdz, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
March 23, 2005
Curdlan sulphate in human severe/cerebral Plasmodium falciparum malaria
I Havlik, S Looareesuwan, S Vannaphan, et al.
The Journal of Experimental Medicine
|
May 1, 1989
Human TCR-gamma+/delta+, CD8+ T lymphocytes recognize tetanus toxoid in an MHC-restricted fashion
D Kozbor, G Trinchieri, D S Monos, et al.
Nature
|
January 23, 1986
Expression of a translocated c-abl gene in hybrids of mouse fibroblasts and chronic myelogenous leukaemia cells
D Kozbor, A Giallongo, M E Sierzega, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 30, 1998
The effect of deletion of the V3 loop of gp120 on cytotoxic T cell responses and HIV gp120-mediated pathogenesis
D Kmieciak, T J Wasik, H Teppler, et al.
International Immunology
|
January 14, 1999
The effect of epitope variation on the profile of cytotoxic T lymphocyte responses to the HIV envelope glycoprotein
D Kmieciak, I Bednarek, M Takiguchi, et al.
Immunology
|
July 1, 1982
Further studies of natural killer cell function in Chediak-Higashi patients
J C Roder, T Haliotis, L Laing, et al.
Cancer Immunology, Immunotherapy : CII
|
April 21, 2021
A prime/boost vaccine platform efficiently identifies CD27 agonism and depletion of myeloid-derived suppressor cells as therapies that rationally combine with checkpoint blockade in ovarian cancer
A J R McGray, C Eppolito, A Miliotto, et al.
Page
of 5